Cerus Corporation (CERS)
NASDAQ: CERS · IEX Real-Time Price · USD
1.700
-0.020 (-1.16%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Cerus Market Cap
Cerus has a market cap or net worth of $314.31 million as of July 2, 2024. Its market cap has decreased by -27.46% in one year.
Market Cap
314.31M
Enterprise Value
341.03M
1-Year Change
-27.46%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since December 1, 1998, Cerus's market cap has increased from $155.40M to $314.31M, an increase of 102.26%. That is a compound annual growth rate of 2.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 318.00M | -18.75% |
Dec 29, 2023 | 391.40M | -39.56% |
Dec 30, 2022 | 647.60M | -44.80% |
Dec 31, 2021 | 1.17B | 1.43% |
Dec 31, 2020 | 1.16B | 92.90% |
Dec 31, 2019 | 599.60M | -12.84% |
Dec 31, 2018 | 687.90M | 78.40% |
Dec 29, 2017 | 385.60M | -14.33% |
Dec 30, 2016 | 450.10M | -26.68% |
Dec 31, 2015 | 613.90M | 25.70% |
Dec 31, 2014 | 488.40M | 7.48% |
Dec 31, 2013 | 454.40M | 159.21% |
Dec 31, 2012 | 175.30M | 30.14% |
Dec 30, 2011 | 134.70M | 36.89% |
Dec 31, 2010 | 98.40M | 27.79% |
Dec 31, 2009 | 77.00M | 237.72% |
Dec 31, 2008 | 22.80M | -89.05% |
Dec 31, 2007 | 208.30M | 27.79% |
Dec 29, 2006 | 163.00M | -28.38% |
Dec 30, 2005 | 227.60M | 247.48% |
Dec 31, 2004 | 65.50M | -34.63% |
Dec 31, 2003 | 100.20M | -70.69% |
Dec 31, 2002 | 341.90M | -52.47% |
Dec 31, 2001 | 719.30M | -31.92% |
Dec 29, 2000 | 1.06B | 240.04% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jasper Therapeutics | 342.44M |
Xeris Biopharma Holdings | 333.58M |
Sight Sciences | 331.87M |
Tourmaline Bio | 329.81M |
Vanda Pharmaceuticals | 328.82M |
Kyverna Therapeutics | 323.36M |
Foghorn Therapeutics | 318.14M |
C4 Therapeutics | 317.88M |